Home > Insider Trading > Filing (0001209191-14-038851)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1087432	Intermune Inc	ITMN	Pharmaceutical Preparations (2834)	943296648

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1304113	William Kenneth Andrew Powell	3280 Bayshore Blvd Brisbane CA 94005	Evp, Gc & Secretary	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2014-04-30	1,277	$12.31	32,027	No	5	J	Direct
Common Stock	Disposition	2014-05-29	500	$39.56	31,527	No	4	S	Direct
Common Stock	Disposition	2014-05-30	500	$39.32	31,027	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	5	J	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Restricted stock units	Acquisiton	2014-05-29	3,500	$0.00	3,500	$0.00
Common Stock	Performance stock units	Acquisiton	2014-05-29	5,250	$0.00	5,250	$0.00
Common Stock	Stock options (right to buy)	Acquisiton	2014-05-29	17,500	$0.00	17,500	$40.26

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
3,500		No	4	A	Direct
5,250		No	4	A	Direct
17,500	2021-05-28	No	4	A	Direct

Footnotes

Reflects acquisition of shares in a transaction exempt from Section 16(b) of the Securities Exchange Act under InterMune, Inc. Employee Stock Purchase Plan.
Each restricted stock unit represents a contingent right to receive one share of InterMune, Inc. common stock.
Twenty-five percent (25%) of the total number of restricted stock units shall become vested and releasable on each yearly anniversary of the grant date. Shares of common stock of the company issued upon completion of vesting of each installment of the restricted stock units will be delivered to the reporting person following the completion of vesting of the corresponding installment.
Each performance stock unit represents a contingent right to receive one share of InterMune, Inc. common stock.
Performance stock units are subject to vest upon pre-specified performance criteria, as determined by the Board of Directors.
Twenty-five percent (25%) of the total number of shares subject to the stock option vest and become exercisable on the first anniversary of the grant date. The remainder of the option shares vests and becomes exercisable cumulatively in equal monthly installments over the following thirty-six (36) months.